Highlights
- 1Journal of neuroinflammation · 2020
- 2ACS chemical neuroscience · 2020
- 3Molecular neurodegeneration · 2025
Publications
60 publications
Funding
15 grantsView NIH portfolio on RePORTER ↗
Active
6 grants- MPICH25H mediates microglial neuroinflammation and tau toxicities in ADNational Institute on Aging · 2025–2030R01AG096902-02
- Co-IDiscovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's diseaseNational Institute on Aging · 2024–2029
- Co-IValidating STING as a therapeutic target for Parkinson disease using human iPSC models (MJFF-028881) to 2026 RFA: T2T Neuroinflammation Target ValidationMichael J. Fox Foundation for Parkinson's Research · 2026–2028MJFF-028881
- Co-ISystematic Identification of Biomarkers to Distinguish FTD-Tau from TDP-43Rainwater Charitable Foundation · 2026–2027RCF 261005-01
- KPModeling pathological Tau propagation in human brain cells in vivoBrightFocus Foundation · 2024–2026A2024003F
- Co-IElucidating the Cell-Type Specific Neuroprotective Mechanisms in the APOE3 Christchurch Mutation in Alzheimer's DiseaseNational Institute on Aging · 2023–2026FellowshipF32AG085960-01
Completed grants (9)
- PIEssential roles of DAP12 in tau metabolism and inflammation in Alzheimer's diseaseNational Institute on Aging · 2020–2025R01AG064239-05
- Co-ILinking tau proteostasis with neuronal activity in FTDNational Institute of Neurological Disorders and Stroke · 2018–2023U54NS100717-03
- Co-IThe functions of the endolysosomal system in the interaction between amyloid plaques and microgliaCornell University - Ithaca · 2018–2020CU 190470-01
- Co-IMolecular mechanisms in progranulin deficient frontotemporal dementiaNational Institute on Aging · 2019–2020R01AG051390-05
- PIRetromer Chaperone R33 Selectively Promotes Aß Degradation by MicrogliaBrightFocus Foundation · 2016–2019BFF 170911-03
- PIInvestigating the Role of Microglia in Tau Clearance in Alzheimers DiseaseCoins for Alzheimer's Research Trust · 2015–2018CART 180604-02EWOF
- KPEffect of APOE on CNS neurons: Role of LRPNational Institute of Neurological Disorders and Stroke · 2014–2017 · via Washington University, TheR01NS090934-20
News mentions
1 mentionView all WCM news ↗
- Key Signaling Pathway in Immune Cells Could be New Alzheimer’s TargetApril 14, 2022
Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer’s and some other neurodegenerative diseases, suggests a study by Weill Cornell Medicine investigators.
External relationships
Ownership
Aeton Therapeutics Inc.
Other
Aeton Therapeutics Inc.